Visit Our Blog
  • About FDNA™
    • Careers at FDNA
    • Contact
  • Products
    • Face2Gene™
    • FDNA Health™
  • Blog
  • News & Publications
  • Blog

Categories
  • All
  • ACMG
  • Case Study
  • Diagnostic odyssey
  • Events/Conferences
  • Face2Gene
  • Geneticist profile
  • Genomics
  • Phenotyping
  • Rare Diseases
  • Scientific Abstracts
  • Talks
  • Technology
  • Uncategorized
  • Videos

Spanish press highlights Face2Gene AI Technology that helps detect rare syndrome using a patient’s photo

June 27, 2023

By FDNA Team

Face2Gene

Thanks to Face2Gene, doctors have an ally to make the diagnosis

By ALEXIA COLUMBA JEREZ

Publish by ABC News (Spain). Read the original article here.

Recognizing the face of the disease is the idea behind Face2Gene. An application of facial biometrics to diagnose rare genetic diseases. Stefanie Eichner, a member of Face2Gene, confirms that “of the more than 7,000 known genetic disorders”, her company estimates that half are associated with a distinctive facial feature that can be learned and used for diagnosis. These physical traits are called ‘facial gestalt’, the recognizable physical pattern of a genetic syndrome. And not only would it be useful for the theme of rare diseases, but Face2Gene’s technology can help diagnose neurological and developmental disorders. And in the future, experts establish that it could also detect genetic errors, which lead to some types of cancer and autism.

“When you have a child who is different and you don’t have answers to give, and people look at you to ask you more questions, all you can say is ‘We don’t know.’ And then they leave.”

Mother of child with a genetic disease

This is an artificial intelligence that uses the patterns provided by the portraits to develop possible conclusions and provide a list of likely options. Because there are diseases that are identifiable on the face. And thus avoids the patient having to go through an odyssey for his or her diagnosis, often caused precisely by suffering from a disease difficult to recognize. This application in a few minutes allows, so to speak, ‘diagnose by the face’.

Eichner explains  that Moti Shniberg co-founded Face.com, a facial biometrics platform that, as of 2011, recognized more than 18 billion faces on social media and the web. “After selling it to Facebook in 2012, Shniberg and Dr. Lior Wolf focused the powerful image analysis capabilities on one of the most important problems in healthcare and co-founded FDNA. Today, it is the AI-powered global leader to aid in the diagnosis of genetic and developmental disorders.

Antonio Martínez Monseny, paediatrician and clinical geneticist at SJD Barcelona Children’s Hospital who  uses Face2Gene, explains that it is  a free digital application to which you can register by having a corporate email from a health centre and which serves to help doctors and other healthcare professional who see patients with suspected rare diseases in their consultation.

Basically, it states that you have to enter a frontal photo, with the consent of the family or the patient, and then the platform screens the information. And it gives you a list of syndromes with similar values, in order, based on which ones have the best chance of being the right candidate. It is like an ordered differential diagnosis and serves in turn to train the clinical eye of the doctor.

 

Diagnostic Odyssey

Rare  and ultra-rare diseases often attract little investment for drug research and studies, so Face2Gene is a powerful diagnostic ally. The European Union defines as rare any disease that affects less than 5 people per 10,000 inhabitants. 65% of those, according to the WHO, are serious and one in five patients suffers from chronic pain. And studies by the Spanish Federation of Rare Diseases (FEDER) indicate that the average time to access diagnosis in Spain is more than 4 years, and 20% can wait more than a decade.

Something similar happened to Keegan Battavio, a nine-year-old boy whom his mother began to detect that something was wrong. All the development milestones the children achieved as they grew up were delayed in Keegan, from speech to physical activities. The doctors his parents consulted didn’t come up with the correct diagnosis until they saw geneticist and doctor Karen Gripp, also FDNA Chief Medical Officar. Using the Face2Gene application, in a few minutes the results collated suggested that Keegan suffered from Smith-Lemli-Opitz syndrome, a developmental disorder that affects learning and behavior, and occurs in one in 40,000 people.

Another example available to FDNA is  that of Glenn Maughan who took ten years to discover that he has KBG syndrome at the age of 12, and “was the answer to numerous questions that his parents, Annette and Glenn, had been asking for years: Why does he have so many seizures? Why is his gait so unusual? Can you hear us? Why did he start losing some of the early skills he had already acquired?” “Early diagnosis would have helped us a lot,” said Glenn’s mother, Annette Maughan.

At the age of 3 he had his first seizures, followed by another four in the following months. It was the beginning of countless consultations. Epilepsy and autism were considered until finally they found the answer: KBG syndrome, caused by a mutation of the ANKRD11 gene and is associated with developmental delays, cognitive disabilities, behavioral disorders, autism, seizures, hearing loss, skeletal abnormalities and cardiac complications. “When you have a child who is different and you don’t have answers to give, and people look at you to ask you more questions, all you can say is ‘We don’t know.’ And then they leave,” Annette told FDNA.

Montseny points out that he sees Face2Gene as especially useful for beginners doctors, pediatricians or geneticists to help them know and recognize genetic syndromes. “It’s faster than asking for an undirected global study. It helps you shorten the time to diagnostic suspicion and better direct your conclusions.”

 

Unbeatable in its genre

In that sense, Face2Gene’s strength for Eichner is that this first-of-its-kind platform helps researchers accumulate an ever-growing dataset. “Over the past ten years, FDNA has created a database covering 5000 disorders and diseases working with researchers, clinicians and geneticists. 1,500 of these can be detected using only our image analysis algorithms,” she says.

A Nature Medicine study shows that in 91% of cases, the correct syndrome was among the answers provided by Face2Gene. Montseny clarifies that it depends a lot on the quality of the photo, the age of the child and thirdly on how many striking features the child has. And last and very important, if the platform is trained to recognize that genetic syndrome.

Face2Gene is useful especially for children aged 5 years and adults. However, some genetic syndromes have been trained to recognize them in nursing babies younger than 2 years. In fact, Montseny was one of those who helped train the platform in this regard. And he points out that his database of all patient photos is not comparable to any other.

As the geneticist points out, it is also usefor for double diagnoses, children who have two genetic syndromes. “This is rare, but we have several patients in the hospital who are examples of this and Face2Gene helps recognize the second case.”

 

One step further

Added to this is a new Face2Gene algorithm introduced in February, which does not try to identify the specific disorder, but the similarity of a face with that of other patients suffering from the same disease. This was confirmed by the case of two children, one from Germany and one from Norway, that despite having different ethnic features their faces were similar. In this way, it was possible to use a facial algorithm to identify a specific condition when the training data available to the AI is small.

The  AI creates an anonymized mask that is the sum of all patients with the same disorder, with the help of AI. However, Montseny adds that it would be ideal if it were an application that also allowed you to enter data from genetic studies, all in one or make family trees. “And if Face2Gene is so called because it goes from the face to the gene, it could also be applied not only to the face, but to the body, as if it were a  ‘Physical2Gene’ to recognize other physical traits that can guide us,” he says.

In the end, applications such as Face2Gene show that with the help of technology, the phrase “the face is the mirror of the soul and the eyes, its interpreters”, becomes more true.

 

More entries about Face2Gene

Face2Gene
 

Quer dominar o Face2Gene? Veja os tutoriais disponíveis

Face2Gene é um conjunto de tecnologias que visa ajudar os médicos a acelerar o tempo de diagnóstico de condições genéticas Read more

Face2Gene
 

All the tutorials available to help you master Face2Gene

Face2Gene is a suit of technologies that aims to help clinicians to fasten the time of diagnosis of rare and Read more

Face2Gene
 

O Pediatrician View em português, por Dr Pablo J. Videla Vilá

O Dr. Pablo Videla fala sobre o novo Pediatrician View, uma tecnologia recentemente desenvolvida pela FDNA Inc., e disponível no Read more

Face2Gene
 

The importance of assigning a diagnosis to your cases

Face2Gene is an AI-driven tool that uses a set of proprietary algorithms engineered to learn from diagnosed patient photos to Read more

Face2Gene
 

Pediatrician View en español, por el doctor Pablo Videla

El Dr. Pablo Videla habla sobre la Pediatrician View, la nueva tecnología desarrollada por FDNA. Este nuevo algoritmo permite a Read more

Face2Gene
 

Spanish press highlights Face2Gene AI Technology that helps detect rare syndrome using a patient’s photo

Thanks to Face2Gene, doctors have an ally to make the diagnosis By ALEXIA COLUMBA JEREZ Publish by ABC News (Spain). Read more

Face2Gene
 

Use Face2Gene as a Team

Collaborate on Shared Cases with your colleagues leveraging cumulative knowledge Using Face2Gene as a TEAM allows you to securely share Read more

Face2Gene
 

Are you sequencing upfront?

With this new update, healthcare providers can use Face2Gene to search for genes within the phenotypic results. A form of Read more

Face2Gene
 

What’s new in Face2Gene?

Check out the new and improved AI capabilities designed to help you diagnose patients earlier (October 2022 updates): Instantly extract Read more

Rare Diseases
 

KBG Foundation partnered with FDNA to help improve earlier diagnose of KBG Syndrome

Manchester, Md. – KBG Foundation, a U.S.-based nonprofit organisation working to improve the lives of people with KBG Syndrome, is Read more

Face2Gene
 

Patient Matching

Face2Gene Patient Matching aims to use de-identified facial patterns and other clinical data in your case to find phenotypic similarities Read more

Face2Gene
 

Extracting Features From Clinical Notes

DID YOU KNOW: By adding clinical features to your cases in Face2Gene, you increase the possible syndrome matches to 7,000+. NEW: Include features Read more

Face2Gene
 

2018 Year in Review

It was an exciting 2018 for FDNA, as we continued on our path to bring AI-based phenotyping technologies to clinicians, Read more

Events/Conferences
 

What to Do and See at ASHG 2018

San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Read more

Face2GeneTalksVideos
 

The Genomics Collaborative: How to Design the Future of Health—Together

  ThinkGenetic recently hosted a panel discussion among researchers involved in the Genomics Collaborative, an FDNA initiative connecting researchers, clinicians, Read more

Events/Conferences
 

FDNA and Face2Gene Featured at ESHG

  A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s Read more

Events/Conferences
 

What to Do and See at ESHG

The European Society of Human Genetics (ESHG) 42nd Annual  Meeting 2018 MiCo – Milano Congressi · Milan, Italy · June Read more

ACMG
 

Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Read more

ACMG
 

Dr. John Carey: Delineating Genetic Syndromes and Next-Generation Phenotyping

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more

ACMG
 

Dr. Karen Gripp: Face2Gene RESEARCH for Deep Phenotyping of Novel Syndromes

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more

  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Careers at FDNA™

Signup for News


* These fields are required.

© 2011-2023 FDNA INC. www.FDNA.com. All rights reserved.

Face2Gene is a search and reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. Check our Cookie Policy.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT